Daxor Net Income 2010-2011 | DXR

Daxor net income from 2010 to 2011. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Daxor Annual Net Income
(Millions of US $)
2011 $-7
2010 $5
2009 $6
Daxor Quarterly Net Income
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-4
2011-06-30 $-0
2011-03-31 $-1
2010-12-31 $2
2010-09-30 $3
2010-06-30 $0
2010-03-31 $-0
2009-12-31 $-1
2009-09-30 $3
2009-06-30 $6
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.046B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.392B 9.92
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Encompass Health (EHC) United States $8.259B 21.26
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.147B 19.48
RadNet (RDNT) United States $3.314B 96.80
Amedisys (AMED) United States $2.999B 21.25
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
U.S Physical Therapy (USPH) United States $1.516B 39.30
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00